In addition, we show that low NR2F1 transcript levels are associated with upregulation of cell cycle-related genes and high histological grade (grade 3, poorly differentiated, highly proliferative) in human breast cancers, including triple-negative therapy-resistant breast cancers. This evidence concerns the gene NR2F1 and breast carcinoma.